Optimal treatment strategy for hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer patients with 1–2 suspicious axillary lymph node metastases on breast magnetic resonance imaging: upfront surgery vs. neoadjuvant chemotherapy

BACKGROUND: It is unclear whether upfront surgery or neoadjuvant chemotherapy is appropriate for first treatment in hormone receptor (HR)-positive human epidermal growth factor receptor 2 (HER2)-negative breast cancer patients with 1–2 suspicious axillary lymph node (ALN) metastases on preoperative...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung Eun, Ahn, Sung Gwe, Ji, Jung Hwan, Kook, Yoonwon, Jang, Ji Soo, Baek, Seung Ho, Jeong, Joon, Bae, Soong June
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230027/
https://www.ncbi.nlm.nih.gov/pubmed/37265793
http://dx.doi.org/10.3389/fonc.2023.936148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230027/
https://www.ncbi.nlm.nih.gov/pubmed/37265793
http://dx.doi.org/10.3389/fonc.2023.936148

Ejemplares similares